Transcend
- Manufacturer
- IBA | Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc.
- Effective date
- 2022-12-14
- Label type
- OTC ANIMAL DRUG LABEL
- Version
- 6
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:44:11
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
ACTIVE INGREDIENT
Nonphenoxypolyethoxyethanol-Iodine Complex..............5.00%
(Provides 1.0% minimum Titratable Iodine)
INERT INGREDIENTS
Emollients.................................................................12.00%
Other Inerts..............................................................83.00%
(Includes Buffering Agents and Surfactants)
Total: ......................................................................100.00%
This product contains highly effective levels of
free iodine for fast kill of mastitis causing organisms.
WARNING
DO NOT DILUTE THIS PRODUCT.
DO NOT RETURN TEAT DIP LEFT IN THE TEAT DIPPER TO STORAGE CONTAINER.
ENSURE THAT DIPPED TEATS ARE DRY BEFORE EXPOSING THE ANIMALS TO WEATHER CONDITIONS WHICH MAY CAUSE DAMAGE TO THE TEATS.
PROTECT THIS PRODUCT FROM FREEZING.
NOT FOR HUMAN USE
CAUTION: KEEP OUT OF REACH OF CHILDREN.
AVOID CONTACT WITH FOOD. DO NOT TAKE INTERNALLY.
RECOMMENDED PROCEDURES FOR TEAT SANITATION
POST-MILKING (POST-DIPPING)
Immediately after milking, dip all teats full length with TRANSCEND Teat Dip.
Ensure good coverage of all sides of the teats and teat orifices.
GENERAL RECOMMENDATIONS
1. Use teat dip applicators made of plastic or other non-corrosive materials. Do not use cups made of aluminum.
2. When solution in the teat dip cup becomes dirty and/or noticeably loses color, discard remaining contents and refill cup with fresh teat dip.
3. Do not use this product for cleaning or sanitizing equipment.
4. Wash teat dip cups after each milking.
FIRST AID PROCEDURES
EYE CONTACT: Immediately flush eyes with large amounts of fresh, tepid water for at least 15 minutes. Hold eyelids open to ensure complete irrigation of eye and lid tissues. Tilt head to the side and irrigate the eye from the bridge of the nose to the outside of the face. Keep run-off from entering the other eye, mouth or ear. Washing eye within the first few seconds is essential to achieve maximum effectiveness. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists, get medical advice/attention.
SKIN CONTACT: For ready-to-use products, wash any sensitive areas.
INGESTION: Do not induce vomiting. Never give anything by mouth to an unconscious person. Drink large amounts of water. If vomiting occurs keep airways open. Keep head lower than the hips to prevent aspiration into the lungs. Get medical advice/attention.
ALWAYS SEEK IMMEDIATE MEDICAL ATTENTION
FOR MEDICAL EMERGENCIES CALL 1-800-424-9300
Transcend
Transcend
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| IODINE | ACTIVE INGREDIENT | 9679TC07X4 | 1 | |
| IODINE | ACTIVE MOIETY | 9679TC07X4 | 1 | |
| LANOLIN | INACTIVE INGREDIENT | 7EV65EAW6H | 1 | |
| N,N-BIS(2-HYDROXYETHYL)LACTAMIDE | INACTIVE INGREDIENT | 799F0899RL | 1 | |
| POLYETHYLENE GLYCOL 200 | INACTIVE INGREDIENT | R95B8J264J | 1 |
Products#
Every source-derived product name is available through these pages.
- Transcend
- Iodine
- LANOLIN
- N,N-BIS(2-HYDROXYETHYL)LACTAMIDE
- POLYETHYLENE GLYCOL 200
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 29983-1025 | 29983-1025-6, 29983-1025-4, 29983-1025-8, 29983-1025-9 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| IODINE | 9679TC07X4 | ACTIB |
| LANOLIN | 7EV65EAW6H | IACT |
| N,N-BIS(2-HYDROXYETHYL)LACTAMIDE | 799F0899RL | IACT |
| POLYETHYLENE GLYCOL 200 | R95B8J264J | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| POLYETHYLENE GLYCOL 200 | POLYETHYLENE GLYCOL 200 | R95B8J264J | CAPSULE / ORAL | NA | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | EMULSION / TOPICAL | 0.25 %w/w | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | SPRAY / NASAL | NA | ||
| POLYETHYLENE GLYCOL 200 | POLYETHYLENE GLYCOL 200 | R95B8J264J | SOLUTION / ORAL | 1440 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | OINTMENT / OPHTHALMIC | 3 %w/w | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | CREAM / TOPICAL | 10 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | CREAM / VAGINAL | 2 %w/w | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | SHAMPOO / TOPICAL | 2 %w/w | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | OINTMENT / TOPICAL | 10 %w/w | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | OINTMENT / RECTAL | 105 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | LOTION / TOPICAL | 1.5 %w/w | ||
| POLYETHYLENE GLYCOL 200 | POLYETHYLENE GLYCOL 200 | R95B8J264J | OINTMENT / TOPICAL | 39 %w/w | ||
| POLYETHYLENE GLYCOL 200 | POLYETHYLENE GLYCOL 200 | R95B8J264J | DROPS / AURICULAR (OTIC) | 9.98 %w/w |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
